Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of hemoglobin to treat systemic inflammatory response syndrome

Use of hemoglobin to treat systemic inflammatory response syndrome

US Patent 5970985 · Granted Oct 26, 1999

Estimated economic value: $22,704,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and matrix for tissue regeneration2024
Multi-dose concentrate esmolol with benzyl alcohol2014
Colored esmolol concentrate2013
Reduced side-effect hemoglobin compositions2007
Reduced side-effect hemoglobin compositions2003
Chemically modified hemoglobin for burn shock resuscitation2003
Therapeutic use of hemoglobin for preserving tissue viability and reducing reste2002
Use of hemoglobin in the treatment of hypotension2000
Hemoglobin therapy in hemodialysis2000
Use of hemoglobin to treat septic shock2000
Use of hemoglobin to treat septic shock2000
Use of hemoglobin in the treatment of cardiogenic shock2000